Nutraceutical Excipients Market

Nutraceutical Excipients Market by Product Source (Organic Chemicals, Inorganic Chemicals), Functionality (Binders, Colorants, Flavors & Sweeteners), End Product, Formulation, Functionality Application and Region - Global Forecast to 2028

Report Code: FB 6004 Jan, 2024, by marketsandmarkets.com

[391 Pages Report] According to MarketsandMarkets, the nutraceutical excipients market is projected to reach USD 6.1 billion by 2028 from USD 4.2 billion by 2023, at a CAGR of 7.7% during the forecast period in terms of value. Increased focus on preventive care and consumption of supplements has led to a rising demand for nutraceutical excipients.   Innovations in processing technologies are leading to the creation of excipients with improved characteristics. Techniques such as spray drying, freeze-drying, and granulation are enabling the production of excipients with better flowability, compressibility, and consistency.

Nutraceutical Excipients Market

To know about the assumptions considered for the study, Request for Free Sample Report

Nutraceutical Excipients Market

To know about the assumptions considered for the study, download the pdf brochure

Market Dynamics

Driver:Advancements in nanotechnology have brought forth a myriad of innovative features that are poised to significantly propel the growth of the nutraceutical excipients market

Advancements in nanotechnology have introduced a multitude of innovative features poised to drive substantial growth within the nutraceutical excipients market. Operating at the nanoscale level, nanotechnology offers distinct and advantageous functionalities for the development of excipients in the nutraceutical industry. Nano-sized excipients play a pivotal role in enhancing the solubility and bioavailability of active ingredients, facilitating superior absorption and utilization of nutrients in the body, thereby amplifying the effectiveness of nutraceutical products. Moreover, excipients at the nanoscale offer increased stability for delicate nutrients, safeguarding them from degradation and extending the shelf life of nutraceuticals, ensuring their efficacy over prolonged periods. Additionally, nanotechnology enables the creation of targeted delivery systems, allowing precise and specific delivery of nutrients to targeted body tissues or cells, thereby optimizing the efficacy of nutraceuticals while minimizing potential adverse effects.

Restraint :Financial hurdles in nutraceutical excipient innovation

Progressing in the nutraceutical industry mandates crucial R&D investments for pioneering excipient innovations. However, achieving lucrative returns on these investments might diminish owing to challenges in securing patents or contending with formidable competition from existing products, potentially reducing profitability. Nutraceutical excipients, akin to pharmaceuticals, necessitate comprehensive clinical trials to establish safety, efficacy, and compliance with regulatory norms. These trials encompass significant expenses, influencing the overall cost structure of bringing a product to market. Moreover, the intricate and protracted nature of these trials can further escalate expenses. Despite considerable R&D and clinical trial investments, product success remains uncertain. Safety concerns, efficacy issues, or lack of market acceptance can lead to substantial financial losses for companies.

The substantial costs linked to clinical trials, in tandem with regulatory intricacies, pose entry barriers for new entrants in the nutraceutical excipients market. This impedes the introduction of innovative excipients, restraining market expansion.

Opportunity : Emerging trend of high use of excipients with multifunctional properties among key players

The utilization of excipients possessing multifunctional properties presents a significant opportunity in the nutraceutical industry. By consolidating numerous functionalities within a single ingredient, these excipients streamline the formulation process, boosting operational efficiency, and reducing the complexity of formulations. This consolidation not only decreases the number of required excipients but also curtails production costs. Moreover, their diverse capabilities, ranging from enhancing stability and solubility to controlling release and masking unwanted tastes or odors, enable the creation of top-tier nutraceutical products with optimized performance. Furthermore, the multifaceted benefits offered by these excipients align with sustainability goals, reducing waste and energy consumption while supporting clean label trends by enabling formulations with fewer, often natural, ingredients. Overall, the adoption of multifunctional excipients represents a strategic avenue for industry players to enhance efficiency, bolster product quality, foster innovation, and cater to evolving consumer preferences, thereby presenting a considerable opportunity for advancement and growth within the nutraceutical excipients market.

Challenge: Protecting intellectual property in nutraceutical excipient development can be a challenge

The fiercely competitive environment within the nutraceutical excipients market presents difficulties in preserving exclusivity. Rival companies often endeavor to create analogous excipients or find ways to bypass existing patents, resulting in potential disputes or violations. Crafting excipients with distinct functionalities or precise delivery mechanisms necessitates inventive strategies. However, formulating patents to encompass these innovations in a manner that safeguards them against replication while complying with patent laws can be intricate. Additionally, the duration of patents is finite, and the arduous and costly processes required to sustain their validity pose challenges. Once patents expire, excipient formulations become vulnerable to competition from generic or akin products.

Nutraceutical Excipients Market Ecosystem

Key players within this market consist of reputable and financially robust nutraceutical excipient manufacturers. These entities boast extensive industry tenure, offering diversified product portfolios, cutting-edge technologies, and robust global sales and marketing networks. Prominent companies in this market include International Flavors & Fragrances Inc (US), Kerry Group plc (Ireland), Ingredion (US), Sensient Technologies Corporation (US), Associated British Foods plc (UK), BASF SE (Germany), Roquette Frères (France), MEGGLE GmbH & Co. KG (Germany), Cargill, Incorporated (US), Ashland (US), IMCD (Netherlands), Hilmar Cheese Company, Inc (US), Air Liquide (France), Azelis Group (Luxembourg), and Biogrund GmbH (Germany).

Nutraceutical Excipients Market

Taste masking excipients act as catalysts for consumer-friendly nutraceuticals.

Nutraceutical products often contain active ingredients with disagreeable tastes or odors. Taste masking excipients serve as pivotal components in elevating palatability, making these items more appealing and user-friendly, particularly for individuals sensitive to specific flavors. The increasing demand for nutraceutical supplements and functional foods in daily health routines has led to the adoption of taste-masking excipients. These aids enhance product likeability, encouraging consistent usage and adherence to prescribed dosages. Taste-related difficulties frequently affect nutritional supplements intended for children and the elderly. Taste masking excipients facilitate customized formulations tailored to these groups, ensuring improved adherence and consumption rates.

In a competitive market landscape, companies aim to distinguish their offerings. Utilizing taste masking excipients allows manufacturers to set themselves apart by delivering superior-tasting options, differentiating their products from competitors.

The Fillers & Diluents segment is expected to hold the second largest market share in the functionality segment of nutraceutical excipients market.

Fillers & diluents are integral for providing bulk to formulations and ensuring consistent dosages. Their primary role involves creating uniform tablet sizes, facilitating streamlined manufacturing processes, and ensuring even distribution of nutrients. Certain fillers & diluents are specially designed to aid in tablet or capsule disintegration and dissolution, ensuring efficient breakdown in the digestive system for optimal nutrient absorption. They also improve the flow characteristics of formulations, binding ingredients, reducing powder segregation, and enhancing compaction properties during production. Consequently, the fillers & diluents segment is anticipated to play a significant role in the functionality segment of nutraceutical excipients.

North America to dominate the nutraceutical excipients market during the forecast period.

North America is expected to dominate the nutraceutical excipients market during the forecast period from 2023 to 2028 due to several factors. North America's mature nutraceutical market, complemented by its robust pharmaceutical and nutraceutical industries, forms a strong platform for excipient innovation. Renowned for pioneering advancements, the region continually invests in R&D, crafting cutting-edge excipients with superior functionality, improved bioavailability, and precise nutrient delivery. This ongoing commitment to innovation positions North America at the forefront, alluring global industry players. The region boasts a well-established retail infrastructure, offering easy access to nutraceuticals through diverse distribution channels like online platforms, specialty outlets, and conventional supermarkets, fostering nutraceutical excipients market expansion.

Nutraceutical Excipients Market Size, and Share

Key Market Players

The key players in this include International Flavors & Fragrances Inc (US), Kerry Group plc (Ireland), Ingredion (US), Sensient Technologies Corporation (US), Associated British Foods plc (UK), BASF SE (Germany), Roquette Frères (France), MEGGLE GmbH & Co. KG (Germany), Cargill, Incorporated (US), Ashland (US), IMCD (Netherlands), Hilmar Cheese Company, Inc (US), Air Liquide (France), Azelis Group (Luxembourg), and Biogrund GmbH (Germany). These market participants are emphasizing the expansion of their footprint via agreements and partnerships. They maintain a robust presence in North America, Asia Pacific, and Europe, supported by manufacturing facilities and well-established distribution networks spanning across these regions.

Get online access to the report on the World's First Market Intelligence Cloud

  • Easy to Download Historical Data & Forecast Numbers
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
Request Sample

Scope of the Report

Report Metric

Details

Market size estimation

2023–2028

Base year considered

2022

Forecast period considered

2023–2028

Units considered

Value (USD)

Segments Covered

By Functionality, Product Source, Formulation, Functionality Application, End Product, and Region

Regions covered

North America, Europe, South America, Asia Pacific, and RoW

Companies studied

  • International Flavors & Fragrances Inc (US)
  • Kerry Group plc (Ireland)
  • Ingredion (US)
  • Sensient Technologies Corporation (US)
  • Associated British Foods plc (UK)
  • BASF SE (Germany)
  • Roquette Frères (France)
  • MEGGLE GmbH & Co. KG (Germany)
  • Cargill, Incorporated (US)
  • Ashland (US)
  • Hilmar Cheese Company, Inc (US)
  • Air Liquide (France)
  • Azelis Group (Luxembourg)
  • Biogrund GmbH (Germany)
  • IMCD (Netherlands)
  • Innophos (US)
  • JRS PHARMA (Germany)
  • Omya AG (Switzerland)
  • Daicel Corporation (Japan)  
  • Alsiano A/S (Denmark)
  • Colorcon (US)
  • Fuji Chemical Industries Co., Ltd (Japan)
  • Jigs Chemical (India)  
  • Panchamrut Chemicals (India)
  • GATTEFOSSE (France)  

This research report categorizes the nutraceutical excipients market, based on functionality, product source, functionality application, end product, formulation, and region.

Target Audience

  • Nutraceutical excipient traders, retailers, and distributors
  • Nutraceutical excipient manufacturers & suppliers
  • Related government authorities, commercial research & development (R&D) institutions, FDA, EFSA, USDA government agencies & NGOs, and other regulatory bodies
  • Regulatory bodies, including government agencies and NGOs.
  • Commercial research & development (R&D) institutions and financial institutions
  • Government and research organizations
  • Venture capitalists and investors
  • Technology providers to nutraceutical excipients and nutraceutical excipients companies
  • Associations and industry bodies

Nutraceutical Excipients Market:

By Product Source
  • Organic Chemicals
  • Inorganic Chemicals
  • Other Chemicals
By Functionality
  • Fillers & Diluents
  • Suspending & Viscosity Agents
  • Coating Agents
  • Binders
  • Flavoring Agents & Sweeteners
  • Disintegrants
  • Colorants
  • Lubricants & Glidants
  • Preservatives
  • Emulsifying Agents
  • Other Functionalities
By Formulation
  • Dry
    • Tablets
    • Capsules
  • Liquid
  • Other Formulations
By Functionality Application
  • Taste Masking
  • Stabilizers
  • Modified-Release
  • Solubility & Bioavailability
  • Others
By End Product
  • Protein & Amino Acids
  • Omega-3 Fatty Acids
  • Vitamins
  • Minerals
  • Prebiotics
  • Probiotics
  • Other End Products
By Region:
  • North America
  • South America
  • Europe
  • Asia Pacific
  • Rest of the World (RoW)

Recent Developments

  • In September 2022, Roquette, renowned for its expertise in plant-based ingredients and its prominent position as a supplier of pharmaceutical and nutraceutical excipients, finalized the acquisition of Crest Cellulose, an excipient manufacturer based in India. Building upon its prior acquisition of a majority stake in 2018, this recent development underscores Roquette's commitment to advancing its robust expansion goals and addressing the increasing worldwide need for top-tier plant-based excipients. This strategic move aligns with Roquette's endeavors to meet the escalating global demand for high-quality excipients derived from plant sources.
  • In February 2021, IFF finalized the merger with DuPont's Nutrition & Biosciences (N&B) division, creating a dominant force in the global ingredients and solutions sector. This amalgamation establishes a leader serving consumer-focused markets such as food & beverage, home & personal care, and health & wellness. Additionally, IFF now offers excipients obtained through the acquisition of DuPont's Nutrition & Biosciences business.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS
 
1 INTRODUCTION (Page No. - 43)
    1.1 STUDY OBJECTIVES 
           1.1.1 MARKET DEFINITION
    1.2 MARKET SCOPE 
           1.2.1 MARKET SEGMENTATION
                    FIGURE 1 NUTRACEUTICAL EXCIPIENTS MARKET SEGMENTATION
           1.2.2 INCLUSIONS & EXCLUSIONS
                    TABLE 1 NUTRACEUTICAL EXCIPIENTS MARKET: INCLUSIONS & EXCLUSIONS
           1.2.3 REGIONS COVERED
    1.3 YEARS CONSIDERED 
    1.4 CURRENCY CONSIDERED 
           TABLE 2 USD EXCHANGE RATES CONSIDERED, 2019–2022
    1.5 STAKEHOLDERS 
    1.6 SUMMARY OF CHANGES 
           1.6.1 RECESSION IMPACT ANALYSIS
 
2 RESEARCH METHODOLOGY (Page No. - 50)
    2.1 RESEARCH DATA 
           FIGURE 2 NUTRACEUTICAL EXCIPIENTS MARKET: RESEARCH DESIGN
           2.1.1 SECONDARY DATA
                    2.1.1.1 Key data from secondary sources
           2.1.2 PRIMARY DATA
                    2.1.2.1 Key data from primary sources
                    2.1.2.2 Key insights from industry experts
                    2.1.2.3 Breakdown of primary profiles
    2.2 MARKET SIZE ESTIMATION 
           FIGURE 3 BOTTOM-UP APPROACH
           FIGURE 4 TOP-DOWN APPROACH
    2.3 DATA TRIANGULATION 
           FIGURE 5 DATA TRIANGULATION AND MARKET BREAKUP
    2.4 ASSUMPTIONS 
    2.5 RESEARCH LIMITATIONS & ASSOCIATED RISKS 
    2.6 RECESSION IMPACT ANALYSIS 
    2.7 RECESSION MACRO-INDICATORS 
           FIGURE 6 RECESSION MACRO-INDICATORS
           FIGURE 7 GLOBAL INFLATION RATE, 2011–2022
           FIGURE 8 GLOBAL GDP, 2011–2022 (USD TRILLION)
           FIGURE 9 RECESSION INDICATORS AND THEIR IMPACT ON NUTRACEUTICAL EXCIPIENTS MARKET
           FIGURE 10 GLOBAL NUTRACEUTICAL EXCIPIENTS MARKET: EARLIER FORECAST VS. RECESSION FORECAST
 
3 EXECUTIVE SUMMARY (Page No. - 64)
    TABLE 3 NUTRACEUTICAL EXCIPIENTS MARKET SNAPSHOT, 2023 VS. 2028 
    FIGURE 11 NUTRACEUTICAL EXCIPIENTS MARKET, BY PRODUCT SOURCE,  2023 VS. 2028 (USD MILLION) 
    FIGURE 12 NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT, 2023 VS. 2028  (USD MILLION) 
    FIGURE 13 NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023 VS. 2028  (USD MILLION) 
    FIGURE 14 NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2023 VS. 2028  (USD MILLION) 
    FIGURE 15 NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION,  2023 VS. 2028 (USD MILLION) 
    FIGURE 16 NUTRACEUTICAL EXCIPIENTS MARKET: REGIONAL SNAPSHOT 
 
4 PREMIUM INSIGHTS (Page No. - 70)
    4.1 BRIEF OVERVIEW OF NUTRACEUTICAL EXCIPIENTS MARKET 
           FIGURE 17 HEALTH-CONSCIOUS CONSUMERS, PREVENTIVE HEALTHCARE, AND PERSONALIZED NUTRITION TRENDS TO DRIVE MARKET GROWTH
    4.2 NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET,  BY FUNCTIONALITY AND KEY COUNTRY 
           FIGURE 18 COATING AGENTS ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN NUTRACEUTICAL EXCIPIENTS MARKET IN 2022
    4.3 NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION 
           FIGURE 19 NORTH AMERICA TO DOMINATE NUTRACEUTICAL EXCIPIENTS MARKET FROM 2023 TO 2028 (USD MILLION)
    4.4 NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION 
           FIGURE 20 DRY SEGMENT ESTIMATED TO BE LARGEST THROUGHOUT FORECAST PERIOD (USD MILLION)
    4.5 NUTRACEUTICAL EXCIPIENTS MARKET, BY PRODUCT SOURCE 
           FIGURE 21 ORGANIC CHEMICALS TO BE LARGEST SEGMENT DURING FORECAST PERIOD (USD MILLION)
    4.6 NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION 
           FIGURE 22 MODIFIED RELEASE TO HOLD LARGEST SHARE IN NUTRACEUTICAL EXCIPIENTS MARKET DURING FORECAST PERIOD (USD MILLION)
    4.7 NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT 
           FIGURE 23 PROBIOTICS TO BE LARGEST SEGMENT DURING FORECAST PERIOD (USD MILLION)
           FIGURE 24 CHINA, INDIA, AND SOUTH KOREA TO GROW AT HIGH RATES DURING  FORECAST PERIOD
 
5 MARKET OVERVIEW (Page No. - 75)
    5.1 INTRODUCTION 
    5.2 MACROECONOMIC INDICATORS 
           5.2.1 GLOBAL POPULATION WITNESSING HIGH PREVALENCE OF OBESITY
           5.2.2 AGING POPULATION BECOMING MORE AWARE OF BENEFITS OF NUTRACEUTICALS
                    FIGURE 25 US POPULATION AGED 65 AND OLDER, 2000–2060 (MILLION)
    5.3 MARKET DYNAMICS 
           FIGURE 26 NUTRACEUTICAL EXCIPIENTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
           5.3.1 DRIVERS
                    5.3.1.1 Increased focus on preventive care to encourage investments in products/solutions
                               FIGURE 27 NUMBER OF AMERICANS WITH CHRONIC CONDITIONS
                    5.3.1.2 Advancements in nanotechnology equipped with new features relating to nutraceutical excipients
                    5.3.1.3 Rise in demand for fortified food products due to increased health consciousness
                    5.3.1.4 Mandates on food fortification by government organizations
                               TABLE 4 PREVALENCE OF THREE MAJOR MICRONUTRIENT DEFICIENCIES, BY REGION
           5.3.2 RESTRAINTS
                    5.3.2.1 Decrease in returns on R&D investments and high costs of clinical trials and registration
           5.3.3 OPPORTUNITIES
                    5.3.3.1 Multi-functionalities of excipients aiding in saving costs and processing time
                    5.3.3.2 Rising awareness of micronutrient deficiencies
           5.3.4 CHALLENGES
                    5.3.4.1 Consumer skepticism associated with nutraceutical products due to rural and semi-urban consumers' perception of dietary supplements as pharmaceutical drugs
 
6 INDUSTRY TRENDS (Page No. - 86)
    6.1 INTRODUCTION 
    6.2 VALUE CHAIN ANALYSIS 
           FIGURE 28 NUTRACEUTICAL EXCIPIENTS MARKET: VALUE CHAIN ANALYSIS
           6.2.1 SOURCING OF RAW MATERIALS
           6.2.2 MANUFACTURING
           6.2.3 DISTRIBUTION, MARKETING, AND SALES
    6.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 
           FIGURE 29 REVENUE SHIFT FOR NUTRACEUTICAL EXCIPIENTS MARKET
    6.4 TECHNOLOGY ANALYSIS 
           6.4.1 FOOD MICROENCAPSULATION
                    6.4.1.1 Encapsulation of omega-3 to mask odor
           6.4.2 INNOVATIVE AND DISRUPTIVE TECH
                    6.4.2.1 Robotics as key technological trend to lead to innovations
                    6.4.2.2 3D printing to uplift future of nutraceutical excipients market with high-end products
    6.5 PRICING ANALYSIS 
           FIGURE 30 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY END PRODUCT,  2019–2022 (USD/TON)
           TABLE 5 NORTH AMERICA: AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY END PRODUCT, 2018–2022 (USD/TON)
           TABLE 6 EUROPE: AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY END PRODUCT,  2018–2022 (USD/TON)
           TABLE 7 ASIA PACIFIC: AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY END PRODUCT, 2018–2022 (USD/TON)
           TABLE 8 SOUTH AMERICA: AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY END PRODUCT, 2018–2022 (USD/TON)
           TABLE 9 ROW: AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY END PRODUCT,  2018–2022 (USD/TON)
    6.6 PATENT ANALYSIS 
           FIGURE 31 LIST OF MAJOR PATENTS GRANTED FOR NUTRACEUTICAL EXCIPIENTS
           FIGURE 32 REGIONAL ANALYSIS OF PATENTS GRANTED FOR NUTRACEUTICAL EXCIPIENTS MARKET, 2012–2022
           6.6.1 LIST OF MAJOR PATENTS
    6.7 ECOSYSTEM/MARKET MAP 
           6.7.1 UPSTREAM
                    6.7.1.1 Excipient Manufacturers
                    6.7.1.2 Technology Providers
           6.7.2 DOWNSTREAM
                    6.7.2.1 Regulatory Bodies
                    6.7.2.2 Nutraceutical Manufacturers
                               FIGURE 33 NUTRACEUTICAL EXCIPIENTS MARKET: ECOSYSTEM
                               TABLE 10 NUTRACEUTICAL EXCIPIENTS MARKET: ECOSYSTEM
    6.8 TRADE SCENARIO 
           TABLE 11 IMPORT DATA OF VITAMINS FOR KEY COUNTRIES, 2022 (VALUE & VOLUME)
           TABLE 12 EXPORT DATA OF VITAMINS FOR KEY COUNTRIES, 2022 (VALUE & VOLUME)
           TABLE 13 IMPORT DATA OF AMINO ACIDS FOR KEY COUNTRIES, 2022 (VALUE & VOLUME)
           TABLE 14 EXPORT DATA OF AMINO ACIDS FOR KEY COUNTRIES, 2022 (VALUE & VOLUME)
    6.9 KEY CONFERENCES & EVENTS, 2023–2024 
           TABLE 15 NUTRACEUTICAL EXCIPIENTS MARKET: DETAILED LIST OF CONFERENCES & EVENTS, 2023–2024
    6.10 TARIFF AND REGULATORY LANDSCAPE 
           6.10.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 16 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 17 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 18 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 19 SOUTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 20 ROW: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
           6.10.2 REGULATORY FRAMEWORK
                    6.10.2.1 ORGANIZATIONS/REGULATIONS GOVERNING NUTRACEUTICAL EXCIPIENTS MARKET
                               TABLE 21 DEFINITIONS & REGULATIONS FOR NUTRACEUTICAL EXCIPIENTS WORLDWIDE
                    6.10.2.2 North America
                               6.10.2.2.1 Canada
                               6.10.2.2.2 US
                               6.10.2.2.3 Mexico
                    6.10.2.3 European Union (EU)
                    6.10.2.4 Asia Pacific
                               6.10.2.4.1 Japan
                               6.10.2.4.2 China
                               6.10.2.4.3 India
                               6.10.2.4.4 Australia & New Zealand
                    6.10.2.5 Rest of the World (RoW)
                               6.10.2.5.1 Israel
                               6.10.2.5.2 Brazil
                    6.10.2.6 Probiotics
                               6.10.2.6.1 Introduction
                               6.10.2.6.2 National/International bodies for safety standards and regulations
                               TABLE 22 DEFINITIONS & REGULATIONS FOR NUTRACEUTICALS WORLDWIDE
                               6.10.2.6.3 Codex alimentarius commission (CAC)
                               6.10.2.6.4 North America: regulatory environment analysis
                                             6.10.2.6.4.1 US
                                             6.10.2.6.4.2 Canada
                               6.10.2.6.5 Asia Pacific: Regulatory environment analysis
                                             6.10.2.6.5.1 Japan
                                             6.10.2.6.5.2 India
                               6.10.2.6.6 South America: Regulatory Environment Analysis
                                             6.10.2.6.6.1 Brazil
                    6.10.2.7 PREBIOTICS
                               6.10.2.7.1 Introduction
                               6.10.2.7.2 Asia Pacific
                                             6.10.2.7.2.1 Japan
                                             6.10.2.7.2.2 Australia & New Zealand
                                             6.10.2.7.2.3 South Korea
                                             6.10.2.7.2.4 India
                               TABLE 23 SCHEDULE – XI OF FOOD SAFETY AND STANDARDS REGULATIONS, 2015, FOR LIST OF APPROVED PREBIOTIC EXCIPIENTS
                               6.10.2.7.3 North America
                                             6.10.2.7.3.1 US
                                             6.10.2.7.3.2 Canada
                               TABLE 24 LIST OF ACCEPTED DIETARY FIBERS BY CANADIAN REGULATORY AUTHORITIES & THEIR SOURCES
                               6.10.2.7.4 European Union
    6.11 PORTER’S FIVE FORCES ANALYSIS 
                    TABLE 25 PORTER’S FIVE FORCES IMPACT ON NUTRACEUTICAL EXCIPIENTS MARKET
           6.11.1 INTENSITY OF COMPETITIVE RIVALRY
           6.11.2 BARGAINING POWER OF SUPPLIERS
           6.11.3 BARGAINING POWER OF BUYERS
           6.11.4 THREAT OF SUBSTITUTES
           6.11.5 THREAT OF NEW ENTRANTS
    6.12 KEY STAKEHOLDERS AND BUYING CRITERIA 
           6.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
                    FIGURE 34 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP 3 TYPES
                    TABLE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP 3 PRODUCT SOURCES (%)
           6.12.2 BUYING CRITERIA
                    TABLE 27 KEY CRITERIA FOR SELECTING SUPPLIER/VENDOR FOR TOP 3 TYPES
                    FIGURE 35 KEY CRITERIA FOR SELECTING SUPPLIER/VENDOR FOR TOP 3 TYPES
    6.13 CASE STUDY ANALYSIS 
           6.13.1 USE CASE 1: FRUNUTTA STARTED OFFERING EASY-TO-USE AND EFFICIENT-TO-TAKE VITAMIN AND MINERAL PILLS THAT DISSOLVE INSTANTLY
           6.13.2 USE CASE 2: EXCIPIENTS OF CHOICE FOR TASTE MASKING TECHNOLOGY WITH HOT MELT EXTRUSION
 
7 NUTRACEUTICAL EXCIPIENTS MARKET, BY PRODUCT SOURCE (Page No. - 125)
    7.1 INTRODUCTION 
           FIGURE 36 NUTRACEUTICAL EXCIPIENTS MARKET, BY PRODUCT SOURCE, 2023 VS. 2028 (USD MILLION)
    7.2 ORGANIC CHEMICALS 
           TABLE 28 ORGANIC EXCIPIENTS MARKET, BY REGION, 2018–2022 (USD MILLION)
           TABLE 29 ORGANIC EXCIPIENTS MARKET, BY REGION, 2023–2028 (USD MILLION)
           TABLE 30 ORGANIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
           TABLE 31 ORGANIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2023–2028 (USD MILLION)
           7.2.1 OLEOCHEMICALS
                    TABLE 32 OLEOCHEMICALS: NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE,  2018–2022 (USD MILLION)
                    TABLE 33 OLEOCHEMICALS: NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE,  2023–2028 (USD MILLION)
                    7.2.1.1 Fatty alcohols
                               7.2.1.1.1 Need for enhancing texture and creaminess likely to propel demand
                    7.2.1.2 Mineral stearates
                               7.2.1.2.1 Mineral stearates to reduce friction and avoid equipment clogging during manufacturing of nutraceuticals
                    7.2.1.3 Glycerin
                               7.2.1.3.1 Glycerin to help improve smoothness and lubrication process
                    7.2.1.4 Other oleochemicals
           7.2.2 CARBOHYDRATES
                    TABLE 34 CARBOHYDRATES: NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE,  2018–2022 (USD MILLION)
                    TABLE 35 CARBOHYDRATES: NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE,  2023–2028 (USD MILLION)
                    7.2.2.1 Sugars
                               TABLE 36 SUGARS: NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE,  2018–2022 (USD MILLION)
                               TABLE 37 SUGARS: NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE,  2023–2028 (USD MILLION)
                               7.2.2.1.1 Actual sugars
                                             7.2.2.1.1.1 Rising diabetic population to fuel need for low-glycemic index alternatives like xylitol and isomaltulose
                               7.2.2.1.2 Sugar alcohols
                                             7.2.2.1.2.1 Various advantageous and unique properties of sugar alcohols to make them attractive option
                               7.2.2.1.3 Artificial sweeteners
                                             7.2.2.1.3.1 Emerging trends in utilization of natural sweeteners in nutraceutical products to drive demand
                    7.2.2.2 Cellulose
                               TABLE 38 CELLULOSE: NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE,  2018–2022 (USD MILLION)
                               TABLE 39 CELLULOSE: NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE,  2023–2028 (USD MILLION)
                               7.2.2.2.1 Microcrystalline cellulose
                                             7.2.2.2.1.1 Rising nutraceutical trend to bolster microcrystalline cellulose demand for superior tablet integrity
                               7.2.2.2.2 Cellulose ethers
                                             7.2.2.2.2.1 Cellulose ethers help streamline nutraceutical rheology
                               7.2.2.2.3 CMC & croscarmellose sodium
                                             7.2.2.2.3.1 Enhanced mouthfeel and fast-acting properties to help propel market growth
                               7.2.2.2.4 Cellulose esters
                                             7.2.2.2.4.1 Rising demand for cellulose esters to provide technical edge in nutraceuticals
                    7.2.2.3 Starch
                               TABLE 40 STARCH: NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE,  2018–2022 (USD MILLION)
                               TABLE 41 STARCH: NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE,  2023–2028 (USD MILLION)
                               7.2.2.3.1 Modified starch
                                             7.2.2.3.1.1 Technical advancements to fuel modified starch demand in nutraceuticals excipients industry
                               7.2.2.3.2 Dried starch
                                             7.2.2.3.2.1 Capabilities such as disintegration enhancement and bulking effects to drive market
                               7.2.2.3.3 Converted starch
                                             7.2.2.3.3.1 Properties such as increased solubility to boost nutrient absorption
           7.2.3 PETROCHEMICALS
                    TABLE 42 PETROCHEMICALS EXCIPIENTS MARKET, BY, SUBTYPE, 2018–2022 (USD MILLION)
                    TABLE 43 PETROCHEMICALS EXCIPIENTS MARKET, BY SUBTYPE, 2023–2028 (USD MILLION)
                    7.2.3.1 Glycols
                               7.2.3.1.1 Humectant & solvent properties to drive demand
                    7.2.3.2 Povidones
                               7.2.3.2.1 Film-forming function to provide controlled release of active ingredients
                    7.2.3.3 Mineral hydrocarbons
                               7.2.3.3.1 Properties such as anti-foaming & lubrication to help in nutraceutical manufacturing
                    7.2.3.4 Acrylic polymers
                               7.2.3.4.1 Diverse functions of acrylic polymers in nutraceuticals to propel growth
                    7.2.3.5 Other petrochemical excipients
           7.2.4 PROTEINS
                    7.2.4.1 Expanding utilization of proteins as carriers for microparticles and nanoparticles to propel market growth
           7.2.5 OTHER ORGANIC CHEMICALS
    7.3 INORGANIC CHEMICALS 
           TABLE 44 INORGANIC EXCIPIENTS MARKET, BY REGION, 2018–2022 (USD MILLION)
           TABLE 45 INORGANIC EXCIPIENTS MARKET, BY REGION, 2023–2028 (USD MILLION)
           TABLE 46 INORGANIC CHEMICALS EXCIPIENTS MARKET, BY SUBTYPE, 2018–2022 (USD MILLION)
           TABLE 47 INORGANIC CHEMICALS EXCIPIENTS MARKET, BY SUBTYPE, 2023–2028 (USD MILLION)
           7.3.1 CALCIUM PHOSPHATE
                    7.3.1.1 Nutraceutical production to be optimized by utilizing GMO-free calcium phosphates as GRAS excipients
           7.3.2 METAL OXIDES
                    7.3.2.1 Metal oxides to help meet rising demand for iron-enriched nutraceuticals
           7.3.3 HALITES
                    7.3.3.1 Halites to ensure taste improvement and salting-out techniques
           7.3.4 CALCIUM CARBONATE
                    7.3.4.1 Focus on R&D of calcium carbonate to help launch new products
           7.3.5 CALCIUM SULFATE
                    7.3.5.1 Improved flowability to drive demand for calcium sulfate
           7.3.6 OTHER INORGANIC CHEMICALS
    7.4 OTHER CHEMICALS 
           TABLE 48 OTHER CHEMICALS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION,  2018–2022 (USD MILLION)
           TABLE 49 OTHER CHEMICALS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION,  2023–2028 (USD MILLION)
 
8 NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT (Page No. - 146)
    8.1 INTRODUCTION 
           TABLE 50 NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT, 2018–2022 (USD MILLION)
           TABLE 51 NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT, 2023–2028 (USD MILLION)
           FIGURE 37 NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT, 2023 VS. 2028
    8.2 PROBIOTICS 
           8.2.1 INCREASING INCLINATION OF CONSUMERS TOWARD IMMUNITY-ENHANCING PRODUCTS POST-COVID-19 TO DRIVE MARKET GROWTH
                    TABLE 52 PROBIOTICS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION,  2018–2022 (USD MILLION)
                    TABLE 53 PROBIOTICS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION,  2023–2028 (USD MILLION)
    8.3 PREBIOTICS 
           8.3.1 INCREASE IN DIGESTIVE ISSUES AMONG CONSUMERS RESULTING IN ACIDITY AND INFLAMMATORY ISSUES, TO ENCOURAGE CONSUMPTION OF PREBIOTICS AS PREVENTIVE MEASURE
                    TABLE 54 PREBIOTICS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION,  2018–2022 (USD MILLION)
                    TABLE 55 PREBIOTICS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION,  2023–2028 (USD MILLION)
    8.4 PROTEINS & AMINO ACIDS 
           8.4.1 INCREASED POPULARITY OF PROTEINS AND AMINO ACIDS AMONG YOUTH TO DRIVE GROWTH OF NUTRACEUTICAL EXCIPIENTS MARKET
                    TABLE 56 PROTEINS & AMINO ACIDS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION,  2018–2022 (USD MILLION)
                    TABLE 57 PROTEINS & AMINO ACIDS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION,  2023–2028 (USD MILLION)
    8.5 VITAMINS 
           8.5.1 PREVALENCE OF VITAMIN DEFICIENCIES AMONG CONSUMERS TO DRIVE MARKET GROWTH FOR NUTRACEUTICAL EXCIPIENTS
                    TABLE 58 VITAMINS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION,  2018–2022 (USD MILLION)
                    TABLE 59 VITAMINS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION,  2023–2028 (USD MILLION)
                    TABLE 60 LIST OF NUTRIENTS AND THEIR RELEVANCE
    8.6 MINERALS 
           8.6.1 BENEFITS OFFERED FOR OPTIMAL FUNCTIONING OF BRAIN AND HEART TO DRIVE GROWTH OF NUTRACEUTICAL EXCIPIENTS MARKET
                    TABLE 61 MINERALS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION,  2018–2022 (USD MILLION)
                    TABLE 62 MINERALS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION,  2023–2028 (USD MILLION)
    8.7 OMEGA-3 FATTY ACIDS 
           8.7.1 INCREASE IN HEART DISEASES TO DRIVE DEMAND FOR OMEGA-3 FATTY ACIDS SUPPLEMENTS
                    TABLE 63 OMEGA-3 FATTY ACIDS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION,  2018–2022 (USD MILLION)
                    TABLE 64 OMEGA-3 FATTY ACIDS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION,  2023–2028 (USD MILLION)
    8.8 OTHER END PRODUCTS 
           TABLE 65 OTHER END PRODUCTS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION,  2018–2022 (USD MILLION)
           TABLE 66 OTHER END PRODUCTS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION,  2023–2028 (USD MILLION)
 
9 NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION (Page No. - 158)
    9.1 INTRODUCTION 
           TABLE 67 NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2018–2022 (USD MILLION)
           TABLE 68 NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2023–2028 (USD MILLION)
           FIGURE 38 NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2023 VS. 2028
    9.2 DRY 
           TABLE 69 DRY: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018–2022 (USD MILLION)
           TABLE 70 DRY: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023–2028 (USD MILLION)
           9.2.1 TABLETS
                    9.2.1.1 Easy to carry and portable nature to make them attractive option
           9.2.2 CAPSULES
                    9.2.2.1 Quick-dissolving capsule shells for targeted absorption to be ideal for nutraceuticals designed to act in specific areas of digestive tract
    9.3 LIQUID 
           9.3.1 POTENTIAL GROWTH OPPORTUNITIES FOR LIQUID NUTRACEUTICAL EXCIPIENTS DUE TO INNOVATIONS IN FORMULATIONS TO DRIVE GROWTH
                    TABLE 71 LIQUID: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018–2022 (USD MILLION)
                    TABLE 72 LIQUID: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023–2028 (USD MILLION)
    9.4 OTHER FORMULATIONS 
           TABLE 73 OTHER FORMULATIONS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION,  2018–2022 (USD MILLION)
           TABLE 74 OTHER FORMULATIONS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION,  2023–2028 (USD MILLION)
 
10 NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY (Page No. - 165)
     10.1 INTRODUCTION 
               TABLE 75 NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2018–2022 (USD MILLION)
               TABLE 76 NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023–2028 (USD MILLION)
               FIGURE 39 NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,  2023 VS. 2028
     10.2 BINDERS 
             10.2.1 INCREASED ACCEPTABILITY AND USE OF BINDING AGENTS IN PRODUCTS TO DRIVE GROWTH OF NUTRACEUTICAL EXCIPIENTS MARKET
                       TABLE 77 BINDERS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION,  2018–2022 (USD MILLION)
                       TABLE 78 BINDERS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION,  2023–2028 (USD MILLION)
     10.3 FILLERS & DILUENTS 
             10.3.1 USE OF ACTIVE INGREDIENTS IN NUTRACEUTICAL PRODUCTS TO ENCOURAGE USE OF FILLERS AND DILUENTS AS EXCIPIENTS
                       TABLE 79 FILLERS & DILUENTS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION,  2018–2022 (USD MILLION)
                       TABLE 80 FILLERS & DILUENTS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION,  2023–2028 (USD MILLION)
     10.4 DISINTEGRANTS 
             10.4.1 HIGH CONSUMPTION OF DIETARY SUPPLEMENTS IN FORM OF ORAL DOSAGES OR TABLETS TO DRIVE GROWTH OF DISINTEGRANTS SEGMENT
                       TABLE 81 DISINTEGRANTS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION,  2018–2022 (USD MILLION)
                       TABLE 82 DISINTEGRANTS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION,  2023–2028 (USD MILLION)
     10.5 COATING AGENTS 
             10.5.1 PROTECTION FROM MOISTURE AND BACTERIA TO DRIVE DEMAND
                       TABLE 83 COATING AGENTS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION,  2018–2022 (USD MILLION)
                       TABLE 84 COATING AGENTS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION,  2023–2028 (USD MILLION)
     10.6 FLAVORING AGENTS & SWEETENERS 
             10.6.1 INCREASE IN NEED FOR MASKING STRONG AND UNAPPEALING FLAVORS TO DRIVE GROWTH OF SEGMENT
                       TABLE 85 FLAVORING AGENTS & SWEETENERS: NUTRACEUTICAL EXCIPIENTS MARKET,  BY REGION, 2018–2022 (USD MILLION)
                       TABLE 86 FLAVORING AGENTS & SWEETENERS: NUTRACEUTICAL EXCIPIENTS MARKET,  BY REGION, 2023–2028 (USD MILLION)
     10.7 PRESERVATIVES 
             10.7.1 INHIBITION OF MICROBIAL GROWTH AND MAINTAINING PRODUCT QUALITY AND SAFETY TO DRIVE DEMAND FOR PRESERVATIVES
                       TABLE 87 PRESERVATIVES: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION,  2018–2022 (USD MILLION)
                       TABLE 88 PRESERVATIVES: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION,  2023–2028 (USD MILLION)
     10.8 LUBRICANTS & GLIDANTS 
             10.8.1 INCREASE IN NEED FOR REDUCING FRICTION AND KEEPING FORMULATION INTACT DURING PRODUCTION PROCESS TO DRIVE GROWTH OF SEGMENT
                       TABLE 89 LUBRICANTS & GLIDANTS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION,  2018–2022 (USD MILLION)
                       TABLE 90 LUBRICANTS & GLIDANTS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023–2028 (USD MILLION)
     10.9 SUSPENDING & VISCOSITY AGENTS 
             10.9.1 PREVENTING SETTLING TO HELP MAINTAIN HOMOGENEITY AND STABILITY OF PRODUCT
                       TABLE 91 SUSPENDING & VISCOSITY AGENTS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018–2022 (USD MILLION)
                       TABLE 92 SUSPENDING & VISCOSITY AGENTS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023–2028 (USD MILLION)
     10.10 COLORANTS 
               10.10.1 NEED FOR VISUAL APPEAL AND PRODUCT DIFFERENTIATION TO FUEL DEMAND FOR COLORANTS
                                   TABLE 93 COLORANTS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION,  2018–2022 (USD MILLION)
                                   TABLE 94 COLORANTS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION,  2023–2028 (USD MILLION)
     10.11 EMULSIFYING AGENTS 
               10.11.1 NEED FOR REDUCING SURFACE TENSION BETWEEN DIFFERENT COMPONENTS TO DRIVE DEMAND FOR EMULSIFYING AGENTS
                                   TABLE 95 EMULSIFYING AGENTS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION,  2018–2022 (USD MILLION)
                                   TABLE 96 EMULSIFYING AGENTS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION,  2023–2028 (USD MILLION)
     10.12 OTHER FUNCTIONALITIES 
                       TABLE 97 OTHER FUNCTIONALITIES: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION,  2018–2022 (USD MILLION)
                       TABLE 98 OTHER FUNCTIONALITIES: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION,  2023–2028 (USD MILLION)
 
11 NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION (Page No. - 181)
     11.1 INTRODUCTION 
               TABLE 99 NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION,  2018–2022 (USD MILLION)
               TABLE 100 NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATI0N,  2023–2028 (USD MILLION)
               FIGURE 40 NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2023 VS. 2028
     11.2 TASTE MASKING 
             11.2.1 CREATING DIFFERENTIATION TO BE KEY IN THIS COMPETITIVE MARKET
                       TABLE 101 TASTE MASKING: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION,  2018–2022 (USD MILLION)
                       TABLE 102 TASTE MASKING: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION,  2023–2028 (USD MILLION)
     11.3 STABILIZERS 
             11.3.1 MAINTAINING DESIRABLE PROPERTIES UNTIL CONSUMPTION TO DRIVE DEMAND FOR STABILIZERS
                       TABLE 103 STABILIZERS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION,  2018–2022 (USD MILLION)
                       TABLE 104 STABILIZERS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION,  2023–2028 (USD MILLION)
     11.4 MODIFIED RELEASE 
             11.4.1 NEED FOR SLOWER AND STEADIER RELEASE OF COMPOUNDS TO PROPEL GROWTH OF MODIFIED-RELEASE APPLICATION IN NUTRACEUTICAL EXCIPIENTS MARKET
                       TABLE 105 MODIFIED RELEASE: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION,  2018–2022 (USD MILLION)
                       TABLE 106 MODIFIED RELEASE: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION,  2023–2028 (USD MILLION)
     11.5 SOLUBILITY & BIOAVAILABILITY ENHANCEMENT 
             11.5.1 CHALLENGES RELATED TO POOR SOLUBILITY AND LIMITED ABSORPTION OF BIOACTIVE COMPOUNDS TO DRIVE DEMAND
                       TABLE 107 SOLUBILITY & BIOAVAILABILITY ENHANCEMENT: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018–2022 (USD MILLION)
                       TABLE 108 SOLUBILITY & BIOAVAILABILITY ENHANCEMENT: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023–2028 (USD MILLION)
     11.6 OTHER FUNCTIONALITY APPLICATIONS 
               TABLE 109 OTHER FUNCTIONALITY APPLICATIONS: NUTRACEUTICAL EXCIPIENTS MARKET,  BY REGION, 2018–2022 (USD MILLION)
               TABLE 110 OTHER FUNCTIONALITY APPLICATIONS: NUTRACEUTICAL EXCIPIENTS MARKET,  BY REGION, 2023–2028 (USD MILLION)
 
12 NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION (Page No. - 189)
     12.1 INTRODUCTION 
               FIGURE 41 NORTH AMERICA TO BE LARGEST MARKET THROUGHOUT FORECAST PERIOD
               FIGURE 42 CHINA, INDIA, AND SOUTH KOREA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
               TABLE 111 NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018–2022 (USD MILLION)
               TABLE 112 NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023–2028 (USD MILLION)
     12.2 NORTH AMERICA 
               FIGURE 43 NORTH AMERICA: MARKET SNAPSHOT
             12.2.1 RECESSION IMPACT ANALYSIS
                       FIGURE 44 NORTH AMERICAN NUTRACEUTICAL EXCIPIENTS MARKET: RECESSION IMPACT ANALYSIS
                       TABLE 113 NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY COUNTRY,  2018–2022 (USD MILLION)
                       TABLE 114 NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY COUNTRY,  2023–2028 (USD MILLION)
                       TABLE 115 NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY PRODUCT SOURCE,  2018–2022 (USD MILLION)
                       TABLE 116 NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY PRODUCT SOURCE,  2023–2028 (USD MILLION)
                       TABLE 117 NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,  2018–2022 (USD MILLION)
                       TABLE 118 NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,  2023–2028 (USD MILLION)
                       TABLE 119 NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION,  2018–2022 (USD MILLION)
                       TABLE 120 NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION,  2023–2028 (USD MILLION)
                       TABLE 121 NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT,  2018–2022 (USD MILLION)
                       TABLE 122 NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT,  2023–2028 (USD MILLION)
                       TABLE 123 NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2018–2022 (USD MILLION)
                       TABLE 124 NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2023–2028 (USD MILLION)
             12.2.2 US
                       12.2.2.1 High concentration of key players, various nutrition awareness programs, and increase in preventive healthcare trends in US
                                   TABLE 125 US: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,  2018–2022 (USD MILLION)
                                   TABLE 126 US: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,  2023–2028 (USD MILLION)
             12.2.3 CANADA
                       12.2.3.1 Demand for quality and cost-competition: Two key factors for manufacturers to consider in Canada
                                   TABLE 127 CANADA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,  2018–2022 (USD MILLION)
                                   TABLE 128 CANADA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,  2023–2028 (USD MILLION)
             12.2.4 MEXICO
                       12.2.4.1 Increase in foreign direct investments and rise in awareness regarding healthier lifestyles associated with dietary supplements
                                   TABLE 129 MEXICO: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,  2018–2022 (USD MILLION)
                                   TABLE 130 MEXICO: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,  2023–2028 (USD MILLION)
     12.3 EUROPE 
             12.3.1 RECESSION IMPACT ANALYSIS
                       FIGURE 45 EUROPEAN NUTRACEUTICAL EXCIPIENTS MARKET: RECESSION IMPACT ANALYSIS
                       TABLE 131 EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY COUNTRY,  2018–2022 (USD MILLION)
                       TABLE 132 EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY COUNTRY,  2023–2028 (USD MILLION)
                       TABLE 133 EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY PRODUCT SOURCE,  2018–2022 (USD MILLION)
                       TABLE 134 EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY PRODUCT SOURCE,  2023–2028 (USD MILLION)
                       TABLE 135 EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,  2018–2022 (USD MILLION)
                       TABLE 136 EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,  2023–2028 (USD MILLION)
                       TABLE 137 EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION,  2018–2022 (USD MILLION)
                       TABLE 138 EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION,  2023–2028 (USD MILLION)
                       TABLE 139 EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT,  2018–2022 (USD MILLION)
                       TABLE 140 EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT,  2023–2028 (USD MILLION)
                       TABLE 141 EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION,  2018–2022 (USD MILLION)
                       TABLE 142 EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION,  2023–2028 (USD MILLION)
             12.3.2 GERMANY
                       12.3.2.1 Demand for nutraceutical excipients likely to increase to serve health-conscious consumers
                                   TABLE 143 GERMANY: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,  2018–2022 (USD MILLION)
                                   TABLE 144 GERMANY: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,  2023–2028 (USD MILLION)
             12.3.3 FRANCE
                       12.3.3.1 Innovations in product formulations to cater to increased consumer demands
                                   TABLE 145 FRANCE: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,  2018–2022 (USD MILLION)
                                   TABLE 146 FRANCE: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,  2023–2028 (USD MILLION)
             12.3.4 UK
                       12.3.4.1 Growth of functional/fortified food & beverage industry in UK to drive demand for nutraceutical excipients
                                   TABLE 147 UK: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,  2018–2022 (USD MILLION)
                                   TABLE 148 UK: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,  2023–2028 (USD MILLION)
             12.3.5 ITALY
                       12.3.5.1 Growing trend of online OTC and food supplement purchases in Italy
                                   TABLE 149 ITALY: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,  2018–2022 (USD MILLION)
                                   TABLE 150 ITALY: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,  2023–2028 (USD MILLION)
             12.3.6 SPAIN
                       12.3.6.1 Growth of food supplements, sports nutrition, and healthcare care markets likely to create favorable environment for nutraceutical excipients
                                   TABLE 151 SPAIN: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,  2018–2022 (USD MILLION)
                                   TABLE 152 SPAIN: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,  2023–2028 (USD MILLION)
             12.3.7 REST OF EUROPE
                       TABLE 153 REST OF EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,  2018–2022 (USD MILLION)
                       TABLE 154 REST OF EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,  2023–2028 (USD MILLION)
     12.4 ASIA PACIFIC 
               FIGURE 46 ASIA PACIFIC: MARKET SNAPSHOT
             12.4.1 RECESSION IMPACT ANALYSIS
                       FIGURE 47 ASIA PACIFIC NUTRACEUTICAL EXCIPIENTS MARKET: RECESSION IMPACT ANALYSIS
                       TABLE 155 ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY COUNTRY,  2018–2022 (USD MILLION)
                       TABLE 156 ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY COUNTRY,  2023–2028 (USD MILLION)
                       TABLE 157 ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY PRODUCT SOURCE,  2018–2022 (USD MILLION)
                       TABLE 158 ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY PRODUCT SOURCE,  2023–2028 (USD MILLION)
                       TABLE 159 ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,  2018–2022 (USD MILLION)
                       TABLE 160 ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,  2023–2028 (USD MILLION)
                       TABLE 161 ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION,  2018–2022 (USD MILLION)
                       TABLE 162 ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION,  2023–2028 (USD MILLION)
                       TABLE 163 ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT,  2018–2022 (USD MILLION)
                       TABLE 164 ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT,  2023–2028 (USD MILLION)
                       TABLE 165 ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2018–2022 (USD MILLION)
                       TABLE 166 ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2023–2028 (USD MILLION)
             12.4.2 CHINA
                       12.4.2.1 Rise in preference for nutraceutical products and innovations in dietary supplement formulations and fortified food products
                                   TABLE 167 CHINA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,  2018–2022 (USD MILLION)
                                   TABLE 168 CHINA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,  2023–2028 (USD MILLION)
             12.4.3 JAPAN
                       12.4.3.1 Manufacturers should think beyond pills & innovation to tap this growing market in Japan
                                   TABLE 169 JAPAN: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,  2018–2022 (USD MILLION)
                                   TABLE 170 JAPAN: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,  2023–2028 (USD MILLION)
             12.4.4 INDIA
                       12.4.4.1 Government policies and importance of nutraceuticals in daily life
                                   TABLE 171 INDIA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,  2018–2022 (USD MILLION)
                                   TABLE 172 INDIA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,  2023–2028 (USD MILLION)
             12.4.5 SOUTH KOREA
                       12.4.5.1 Rapid growth of supplements industry in South Korea
                                   TABLE 173 SOUTH KOREA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,  2018–2022 (USD MILLION)
                                   TABLE 174 SOUTH KOREA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,  2023–2028 (USD MILLION)
             12.4.6 REST OF ASIA PACIFIC
                       TABLE 175 REST OF ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,  2018–2022 (USD MILLION)
                       TABLE 176 REST OF ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,  2023–2028 (USD MILLION)
     12.5 SOUTH AMERICA 
             12.5.1 RECESSION IMPACT ANALYSIS
                       FIGURE 48 SOUTH AMERICAN NUTRACEUTICAL EXCIPIENTS MARKET: RECESSION IMPACT ANALYSIS
                       TABLE 177 SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY COUNTRY,  2018–2022 (USD MILLION)
                       TABLE 178 SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY COUNTRY,  2023–2028 (USD MILLION)
                       TABLE 179 SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY PRODUCT SOURCE,  2018–2022 (USD MILLION)
                       TABLE 180 SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY PRODUCT SOURCE,  2023–2028 (USD MILLION)
                       TABLE 181 SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,  2018–2022 (USD MILLION)
                       TABLE 182 SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,  2023–2028 (USD MILLION)
                       TABLE 183 SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION,  2018–2022 (USD MILLION)
                       TABLE 184 SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION,  2023–2028 (USD MILLION)
                       TABLE 185 SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT,  2018–2022 (USD MILLION)
                       TABLE 186 SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT,  2023–2028 (USD MILLION)
                       TABLE 187 SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2018–2022 (USD MILLION)
                       TABLE 188 SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2023–2028 (USD MILLION)
             12.5.2 BRAZIL
                       12.5.2.1 Growth in awareness regarding benefits of functional foods and rise in aging population in Brazil
                                   TABLE 189 BRAZIL: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,  2018–2022 (USD MILLION)
                                   TABLE 190 BRAZIL: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,  2023–2028 (USD MILLION)
             12.5.3 ARGENTINA
                       12.5.3.1 Country’s focus on prevention healthcare system to be positive sign for nutraceutical excipients market
                                   TABLE 191 ARGENTINA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,  2018–2022 (USD MILLION)
                                   TABLE 192 ARGENTINA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,  2023–2028 (USD MILLION)
             12.5.4 REST OF SOUTH AMERICA
                       TABLE 193 REST OF SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2018–2022 (USD MILLION)
                       TABLE 194 REST OF SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023–2028 (USD MILLION)
     12.6 REST OF THE WORLD (ROW) 
             12.6.1 RECESSION IMPACT ANALYSIS
                       FIGURE 49 ROW NUTRACEUTICAL EXCIPIENTS MARKET: RECESSION IMPACT ANALYSIS
                       TABLE 195 ROW: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018–2022 (USD MILLION)
                       TABLE 196 ROW: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023–2028 (USD MILLION)
                       TABLE 197 ROW: NUTRACEUTICAL EXCIPIENTS MARKET, BY PRODUCT SOURCE,  2018–2022 (USD MILLION)
                       TABLE 198 ROW: NUTRACEUTICAL EXCIPIENTS MARKET, BY PRODUCT SOURCE,  2023–2028 (USD MILLION)
                       TABLE 199 ROW: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,  2018–2022 (USD MILLION)
                       TABLE 200 ROW: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,  2023–2028 (USD MILLION)
                       TABLE 201 ROW: NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION,  2018–2022 (USD MILLION)
                       TABLE 202 ROW: NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION,  2023–2028 (USD MILLION)
                       TABLE 203 ROW: NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT,  2018–2022 (USD MILLION)
                       TABLE 204 ROW NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT,  2023–2028 (USD MILLION)
                       TABLE 205 ROW: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION,  2018–2022 (USD MILLION)
                       TABLE 206 ROW: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION,  2023–2028 (USD MILLION)
             12.6.2 MIDDLE EAST
                       12.6.2.1 Rise in obesity and other health-related concerns in Middle East
                                   TABLE 207 MIDDLE EAST: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,  2018–2022 (USD MILLION)
                                   TABLE 208 MIDDLE EAST: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,  2023–2028 (USD MILLION)
             12.6.3 AFRICA
                       12.6.3.1 Intra-African trade policies and investments by global nutraceutical players
                                   TABLE 209 AFRICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,  2018–2022 (USD MILLION)
                                   TABLE 210 AFRICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,  2023–2028 (USD MILLION)
 
13 COMPETITIVE LANDSCAPE (Page No. - 253)
     13.1 OVERVIEW 
     13.2 MARKET SHARE ANALYSIS 
               TABLE 211 NUTRACEUTICAL EXCIPIENTS MARKET: DEGREE OF COMPETITION, 2022
     13.3 KEY PLAYER STRATEGIES/RIGHT TO WIN 
               TABLE 212 STRATEGIES ADOPTED BY KEY PLAYERS
     13.4 REVENUE ANALYSIS 
               FIGURE 50 HISTORICAL REVENUE ANALYSIS OF KEY PLAYERS, 2020–2022 (USD BILLION)
     13.5 KEY PLAYER ANNUAL REVENUE VS. GROWTH 
               FIGURE 51 ANNUAL REVENUE, 2022 (USD BILLION) VS. REVENUE GROWTH,  2020–2022 (%)
     13.6 KEY PLAYERS’ EBIT/EBITDA 
               FIGURE 52 EBITDA, 2022 (USD BILLION)
     13.7 GLOBAL SNAPSHOT OF KEY MARKET PARTICIPANTS 
               FIGURE 53 NUTRACEUTICAL EXCIPIENTS MARKET: GLOBAL SNAPSHOT OF KEY MARKET PARTICIPANTS, 2022
     13.8 COMPANY EVALUATION MATRIX (KEY PLAYERS) 
             13.8.1 STARS
             13.8.2 EMERGING LEADERS
             13.8.3 PERVASIVE PLAYERS
             13.8.4 PARTICIPANTS
                       FIGURE 54 COMPANY EVALUATION MATRIX (KEY PLAYERS), 2022
             13.8.5 COMPANY FOOTPRINT
                       TABLE 213 COMPANY FOOTPRINT, BY FUNCTIONALITY
                       TABLE 214 COMPANY FOOTPRINT, BY PRODUCT SOURCE
                       TABLE 215 COMPANY FOOTPRINT, BY REGION
                       TABLE 216 OVERALL COMPANY FOOTPRINT
     13.9 STARTUP/SME EVALUATION MATRIX 
             13.9.1 PROGRESSIVE COMPANIES
             13.9.2 RESPONSIVE COMPANIES
             13.9.3 DYNAMIC COMPANIES
             13.9.4 STARTING BLOCKS
                       FIGURE 55 STARTUP/SME EVALUATION MATRIX, 2022
             13.9.5 COMPETITIVE BENCHMARKING
                       TABLE 217 NUTRACEUTICAL EXCIPIENTS MARKET: DETAILED LIST OF KEY STARTUPS/SMES
                       TABLE 218 NUTRACEUTICAL EXCIPIENTS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES
                       TABLE 219 COMPANY FOOTPRINT, BY FUNCTIONALITY (STARTUPS)
     13.10 COMPETITIVE SCENARIO 
               13.10.1 NEW PRODUCT LAUNCHES
                       TABLE 220 NUTRACEUTICAL EXCIPIENTS MARKET: NEW PRODUCT LAUNCHES, 2019–2023
               13.10.2 DEALS
                       TABLE 221 NUTRACEUTICAL EXCIPIENTS MARKET: DEALS, 2019–2023
               13.10.3 OTHERS
                       TABLE 222 NUTRACEUTICAL EXCIPIENTS MARKET: OTHERS, 2019–2023
 
14 COMPANY PROFILES (Page No. - 289)
(Business Overview, Products Offered, Recent Developments, MnM View Right to win, Strategic choices made, Weaknesses and competitive threats) *
     14.1 KEY PLAYERS 
             14.1.1 INTERNATIONAL FLAVORS & FRAGRANCES INC
                       TABLE 223 INTERNATIONAL FLAVORS & FRAGRANCES INC: BUSINESS OVERVIEW
                       FIGURE 56 INTERNATIONAL FLAVORS & FRAGRANCES INC: COMPANY SNAPSHOT
                       TABLE 224 INTERNATIONAL FLAVORS & FRAGRANCES INC: PRODUCTS/SOLUTIONS/SERVICES OFFERED
                       TABLE 225 INTERNATIONAL FLAVORS & FRAGRANCES INC: PRODUCT LAUNCHES
                       TABLE 226 INTERNATIONAL FLAVORS & FRAGRANCES INC: DEALS
             14.1.2 KERRY GROUP PLC
                       TABLE 227 KERRY GROUP PLC: BUSINESS OVERVIEW
                       FIGURE 57 KERRY GROUP PLC: COMPANY SNAPSHOT
                       TABLE 228 KERRY GROUP PLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED
                       TABLE 229 KERRY GROUP PLC: DEALS
             14.1.3 INGREDION
                       TABLE 230 INGREDION: BUSINESS OVERVIEW
                       FIGURE 58 INGREDION: COMPANY SNAPSHOT
                       TABLE 231 INGREDION: PRODUCTS/SOLUTIONS/SERVICES OFFERED
                       TABLE 232 INGREDION: DEALS
             14.1.4 SENSIENT TECHNOLOGIES CORPORATION
                       TABLE 233 SENSIENT TECHNOLOGIES CORPORATION: BUSINESS OVERVIEW
                       FIGURE 59 SENSIENT TECHNOLOGIES CORPORATION: COMPANY SNAPSHOT
                       TABLE 234 SENSIENT TECHNOLOGIES CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED
                       TABLE 235 SENSIENT TECHNOLOGIES CORPORATION: DEALS
             14.1.5 ASSOCIATED BRITISH FOODS PLC
                       TABLE 236 ASSOCIATED BRITISH FOODS PLC: BUSINESS OVERVIEW
                       FIGURE 60 ASSOCIATED BRITISH FOODS PLC: COMPANY SNAPSHOT
                       TABLE 237 ASSOCIATED BRITISH FOODS PLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED
                       TABLE 238 ASSOCIATED BRITISH FOODS PLC: PRODUCT LAUNCHES
             14.1.6 BASF SE
                       TABLE 239 BASF SE: BUSINESS OVERVIEW
                       FIGURE 61 BASF SE: COMPANY SNAPSHOT
                       TABLE 240 BASF SE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
                       TABLE 241 BASF SE: DEALS
                       TABLE 242 BASF SE: OTHERS
             14.1.7 ROQUETTE FRÈRES
                       TABLE 243 ROQUETTE FRÈRES: BUSINESS OVERVIEW
                       TABLE 244 ROQUETTE FRÈRES: PRODUCTS/SOLUTIONS/SERVICES OFFERED
                       TABLE 245 ROQUETTE FRÈRES: PRODUCT LAUNCHES
                       TABLE 246 ROQUETTE FRÈRES: DEALS
                       TABLE 247 ROQUETTE FRÈRES: OTHERS
             14.1.8 MEGGLE GROUP GMBH
                       TABLE 248 MEGGLE GROUP GMBH: BUSINESS OVERVIEW
                       TABLE 249 MEGGLE GROUP GMBH: PRODUCTS/SOLUTIONS/SERVICES OFFERED
             14.1.9 CARGILL, INCORPORATED
                       TABLE 250 CARGILL, INCORPORATED: BUSINESS OVERVIEW
                       FIGURE 62 CARGILL, INCORPORATED: COMPANY SNAPSHOT
                       TABLE 251 CARGILL, INCORPORATED: PRODUCTS/SOLUTIONS/SERVICES OFFERED
                       TABLE 252 CARGILL, INCORPORATED: DEALS
                       TABLE 253 CARGILL, INCORPORATED: OTHERS
             14.1.10 ASHLAND
                       TABLE 254 ASHLAND: BUSINESS OVERVIEW
                       FIGURE 63 ASHLAND: COMPANY SNAPSHOT
                       TABLE 255 ASHLAND: PRODUCTS/SOLUTIONS/SERVICES OFFERED
                       TABLE 256 ASHLAND: PRODUCT LAUNCHES
                       TABLE 257 ASHLAND: OTHERS
             14.1.11 AZELIS GROUP
                       TABLE 258 AZELIS GROUP: BUSINESS OVERVIEW
                       FIGURE 64 AZELIS GROUP: COMPANY SNAPSHOT
                       TABLE 259 AZELIS GROUP: PRODUCTS/SOLUTIONS/SERVICES OFFERED
                       TABLE 260 AZELIS GROUP: DEALS
                       TABLE 261 AZELIS GROUP: OTHERS
             14.1.12 IMCD
                       TABLE 262 IMCD: BUSINESS OVERVIEW
                       FIGURE 65 IMCD: COMPANY SNAPSHOT
                       TABLE 263 IMCD: PRODUCTS/SOLUTIONS/SERVICES OFFERED
                       TABLE 264 IMCD: DEALS
                       TABLE 265 IMCD: OTHERS
             14.1.13 HILMAR CHEESE COMPANY, INC.
                       TABLE 266 HILMAR CHEESE COMPANY, INC: BUSINESS OVERVIEW
                       TABLE 267 HILMAR CHEESE COMPANY, INC: PRODUCTS/SOLUTIONS/SERVICES OFFERED
             14.1.14 SEPPIC
                       TABLE 268 SEPPIC: BUSINESS OVERVIEW
                       TABLE 269 SEPPIC: PRODUCTS/SOLUTIONS/SERVICES OFFERED
                       TABLE 270 SEPPIC: PRODUCT LAUNCHES
             14.1.15 BIOGRUND GMBH
                       TABLE 271 BIOGRUND GMBH: BUSINESS OVERVIEW
                       TABLE 272 BIOGRUND GMBH: PRODUCTS/SOLUTIONS/SERVICES OFFERED
     14.2 OTHER PLAYERS 
             14.2.1 INNOPHOS
                       TABLE 273 INNOPHOS: BUSINESS OVERVIEW
                       TABLE 274 INNOPHOS: PRODUCTS/SOLUTIONS/SERVICES OFFERED
                       TABLE 275 INNOPHOS: PRODUCT LAUNCHES
             14.2.2 DAICEL CORPORATION
                       TABLE 276 DAICEL CORPORATION: BUSINESS OVERVIEW
                       FIGURE 66 DAICEL CORPORATION: COMPANY SNAPSHOT
                       TABLE 277 DAICEL CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED
             14.2.3 ALSIANO A/S
                       TABLE 278 ALSIANO A/S: BUSINESS OVERVIEW
                       TABLE 279 ALSIANO A/S: PRODUCTS/SOLUTIONS/SERVICES OFFERED
             14.2.4 JRS PHARMA
                       TABLE 280 JRS PHARMA: BUSINESS OVERVIEW
                       TABLE 281 JRS PHARMA: PRODUCTS/SOLUTIONS/SERVICES OFFERED
                       TABLE 282 JRS PHARMA: OTHERS
             14.2.5 COLORCON
                       TABLE 283 COLORCON: BUSINESS OVERVIEW
                       TABLE 284 COLORCON: PRODUCTS/SOLUTIONS/SERVICES OFFERED
                       TABLE 285 COLORCON: PRODUCT LAUNCHES
                       TABLE 286 COLORCON: DEALS
                       TABLE 287 COLORCON: OTHERS
             14.2.6 PANCHAMRUT CHEMICALS
                       TABLE 288 PANCHAMRUT CHEMICALS: BUSINESS OVERVIEW
             14.2.7 OMYA
                       TABLE 289 OMYA: BUSINESS OVERVIEW
             14.2.8 GATTEFOSSÉ
                       TABLE 290 GATTEFOSSÉ: BUSINESS OVERVIEW
             14.2.9 FUJI CHEMICAL INDUSTRIES CO., LTD
                       TABLE 291 FUJI CHEMICAL INDUSTRIES CO., LTD: BUSINESS OVERVIEW
             14.2.10 JIGS CHEMICAL
                                   TABLE 292 JIGS CHEMICAL: BUSINESS OVERVIEW
*Details on Business Overview, Products Offered, Recent Developments, MnM View, Right to win, Strategic choices made, Weaknesses and competitive threats might not be captured in case of unlisted companies.
 
15 ADJACENT & RELATED MARKETS (Page No. - 377)
     15.1 INTRODUCTION 
     15.2 LIMITATIONS 
     15.3 FUNCTIONAL FOOD INGREDIENTS MARKET 
             15.3.1 MARKET DEFINITION
             15.3.2 MARKET OVERVIEW
             15.3.3 FUNCTIONAL FOOD INGREDIENTS MARKET, BY TYPE
                       15.3.3.1 Introduction
                                   TABLE 293 FUNCTIONAL FOOD INGREDIENTS MARKET, BY TYPE, 2016–2020 (USD MILLION)
                                   TABLE 294 FUNCTIONAL FOOD INGREDIENTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
     15.4 NUTRACEUTICAL INGREDIENTS MARKET 
             15.4.1 MARKET DEFINITION
             15.4.2 MARKET OVERVIEW
             15.4.3 NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE
                       15.4.3.1 Introduction
                                   TABLE 295 NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION)
                                   TABLE 296 NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION)
                                   TABLE 297 NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (KT)
                                   TABLE 298 NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (KT)
 
16 APPENDIX (Page No. - 384)
     16.1 DISCUSSION GUIDE 
     16.2 KNOWLEDGESTORE: MARKETSANDMARKETS’  SUBSCRIPTION PORTAL 
     16.3 CUSTOMIZATION OPTIONS 
     16.4 RELATED REPORTS 
     16.5 AUTHOR DETAILS 

The study involved four major activities in estimating the current size of the nutraceutical excipients market. Exhaustive secondary research was done to collect information on the market, peer market, and parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and subsegments.

Secondary Research

This research study involved the extensive use of secondary sources—directories and databases such as Bloomberg Businessweek and Factiva—to identify and collect information useful for a technical, market-oriented, and commercial study of the nutraceutical excipients market.

In the secondary research process, various sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles from recognized authors, gold & silver standard websites, directories, and databases, were referred to identify and collect information. This research study involved the extensive use of secondary sources—directories and databases such as Bloomberg Businessweek and Factiva—to identify and collect information useful for a technical, market-oriented, and commercial study of the nutraceutical excipients market.

Secondary research was mainly used to obtain key information about the industry’s supply chain, the total pool of key players, and market classification and segmentation as per the industry trends to the bottom-most level, regional markets, and key developments from both market- and technology-oriented perspectives.

Primary Research

Extensive primary research was conducted after obtaining information regarding the nutraceutical excipients market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand and supply sides across major countries of North America, Europe, Asia Pacific, the Middle East & Africa, and South America. Primary data was collected through questionnaires, emails, and telephonic interviews. The primary sources from the supply side included various industry experts, such as Chief X Officers (CXOs), Vice Presidents (VPs), Directors, from business development, marketing, research, and development teams, and related key executives from distributors, and key opinion leaders. Primary interviews were conducted to gather insights such as market statistics, data on revenue collected from the products and services, market breakdowns, market size estimations, market forecasting, and data triangulation. Primary research also helped in understanding the various trends related to functionality, end products, product source, formulation, functionality application, and region.

Nutraceutical Excipients Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both the top-down and bottom-up approaches were used to estimate and validate the total size of the nutraceutical excipients market. These approaches were also used extensively to estimate the size of various dependent submarkets. The research methodology used to estimate the market size includes the following:

  • Key players were identified through extensive secondary research.
  • The industry’s value chain and market size were determined through primary and secondary research.
  • All percentage share splits and breakdowns were determined using secondary sources and verified through primary sources.
  • All the possible parameters that affect the markets covered in this research study were accounted for, viewed in extensive detail, verified through primary research, and analyzed to obtain the final quantitative and qualitative data.
  • The parent market—the crop protection market—was considered further to validate the details of the nutraceutical excipients market.
  • The following figure provides an illustrative representation of the complete market size estimation process implemented in this research study for an overall estimation of the nutraceutical excipients market in a consolidated format.

The following sections (bottom-up & top-down) depict the overall market size estimation process employed for the purpose of this study.

Global Nutraceutical Excipients Market: Bottom-Up Approach

Nutraceutical Excipients Market Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Global Nutraceutical Excipients Market: Top-Down Approach

Nutraceutical Excipients Market Size, and Share

With the data triangulation procedure done both through the bottom-up approach (demand side, by functionality segment) and top-down approach (supply side, by competitor sales revenues), and validation of data through primaries, the overall size of the parent market size and size of each market were determined.

Data Triangulation

After arriving at the overall market size from the estimation process explained above, the total market was split into several segments and subsegments. The data triangulation and market breakdown procedures were employed, wherever applicable, to estimate the overall nutraceutical excipients market and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from the demand and supply sides. Along with this, the market size was validated using both the top-down and bottom-up approaches.

Market Definition

Nutraceutical excipients are non-active nutraceutical ingredients that are included in the production of nutraceutical formulations. Excipients are also used to enhance the therapeutic effects of active ingredients in the final dose. Nutraceutical active ingredients are biologically functional molecules or components, which affect the nutritional uptake, balance, and health of a human body, and that mostly aim to supplement the nutritional profile provided by staple foods. Moreover, excipients are essential for the timely and precise delivery of nutraceutical components. In addition, maintaining optimum levels of active ingredients in nutraceutical products, such as vitamins and minerals, is a key function of excipients.

Key Stakeholders

  • Raw material supplier
  • Commercial Research and Development Institutions
  • Manufacturers, dealers, and suppliers in the nutraceutical excipients market
  • Government bodies
  • Food & beverage manufacturers
  • Nutraceutical manufacturers
  • Cosmetic & skincare product manufacturers
  • Food importers and exporters
  • Associations and NGOs
  • Logistics providers & transporters
  • Regulatory bodies & institutions
    • US Food and Drug Administration (US FDA)
    • European Food Safety Authority (EFSA)
    • Food Safety and Standards Authority of India (FSSAI)
    • Food Safety Law of the People’s Republic of China
    • Food Safety Commission of Japan

Report Objectives

Market Intelligence

  • Determining and projecting the size of the nutraceutical excipients market, based on product source, formulation, functionality, functionality application, end product and regional markets, over a five-year period, ranging from 2023 to 2028.
  • Identifying attractive opportunities in the market by determining the largest and fastest-growing segments across regions
  • Analyzing the demand-side factors based on the following:
    • Impact of macro- and microeconomic factors on the market
    • Shift in demand patterns across different subsegments and regions

Competitive Intelligence

  • Identifying and profiling the key market players in the nutraceutical excipients market
  • Determining the share of key players operating in the nutraceutical excipients market
  • Providing a comparative analysis of the market leaders on the basis of the following:
    • Product offerings
    • Business strategies
    • Strengths, weaknesses, opportunities, and threats
    • Key financials
  • Understanding the competitive landscape and identifying major growth strategies adopted by the key companies.
  • Analyzing the patents registered and regulatory frameworks across the regions and their impact on prominent market players.
  • Analyzing the market dynamics and competitive situations & trends across the regions and their impact on prominent market players

Available Customizations:

With the given market data, MarketsandMarkets offers customizations according to company-specific scientific needs.

The following customization options are available for the report:

Product Analysis

  • Product Matrix, which gives a detailed comparison of the product portfolio of each company.

Geographic Analysis

With the given market data, MarketsandMarkets offers customizations according to company-specific scientific needs.

  • Further breakdown of the Rest of Europe into Netherlands, Poland, and other EU & non-EU countries
  • Further breakdown of the Rest of Asia Pacific into New Zealand, Thailand, and Vietnam.
  • Further breakdown of the Rest of South America into Colombia, Paraguay, Peru, and other South American countries

Company Information

  • Detailed analyses and profiling of additional market players (up to five)
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Request Customization
Report Code
FB 6004
Published ON
Jan, 2024
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Nutraceutical Excipients Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2024 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status Website Feedback